Explore our comprehensive blog category on Good Distribution Practice (GDP), a standard ensuring products are consistently distributed and controlled according to quality standards. Dive into insightful industry updates, and best practices to uphold the highest level of quality assurance in pharmaceutical distribution processes.
The blog post suggests a structured approach to analyze and address these errors, including understanding human behavior and creating a blame-free culture. It underlines the importance of proactive solutions over reac...
Jaap Koster
CEO / Senior GxP Consultant
Avoid common pitfalls in human error handling. Duct tape solutions and excessive procedures don't work. Understand the cause and design error-proof systems.
Jaap Koster
CEO / Senior GxP Consultant
"Exploring the debate between Planned vs. Unplanned Deviations in GMP. Let's focus on real issues like drug shortages, not semantics.
Jaap Koster
CEO / Senior GxP Consultant
Transporters storing medicinal products >72 hours can get a WDA (GDP license). Under 72 hours storage doesn't qualify for WDA or GDP certificate. Voluntary GDP adherence is an option for client satisfaction.
Jaap Koster
CEO / Senior GxP Consultant
The Critical Role of Proper Deviation Management in the Pharmaceutical Industry: Explore the importance of deviation and CAPA management, including impact assessments and root cause analysis, to ensure product quality...
Jaap Koster
CEO / Senior GxP Consultant
Tips for conducting in-depth GMP or GDP audits: Understand different levels of inspection-depth: absence, adherence, and adequacy. Use intellect and intuition to spot issues. Classify findings as critical, major, or m...
Jaap Koster
CEO / Senior GxP Consultant
This blog explores the Tenerife disaster's lessons on human error and communication, drawing parallels to the pharmaceutical industry. It emphasizes the need for clear communication, standardized protocols, and a safe...
Jaap Koster
CEO / Senior GxP Consultant
WDA, or Wholesale Distribution Authorization, is crucial in the pharmaceutical industry. It's required for storing medicinal products for over 72 hours. Learn how to obtain it and navigate post-Brexit regulations for...
Jaap Koster
CEO / Senior GxP Consultant
Navigating the complex landscape of obtaining a Wholesale Distribution Authorization (WDA) license is no easy feat, especially for startups. However, cutting corners and attempting to "hack" your way into compliance c...
Jaap Koster
CEO / Senior GxP Consultant
The Effort Paradox serves as a reminder that knowing isn't the same as doing. In the pharmaceutical industry, where the stakes are high, overcoming this paradox is essential.
Jaap Koster
CEO / Senior GxP Consultant
This blog post addresses 10 common misconceptions in implementing Good Distribution Practice (GDP) within the pharmaceutical supply chain.
Jaap Koster
CEO / Senior GxP Consultant
People want a neat definition, a tidy checklist, or a set of metrics to measure quality. But when you peel back the layers, it becomes clear that “Quality Culture” is more of a broad vision than a well-defined endpoint.
Jaap Koster
CEO / Senior GxP Consultant
Download our training brochure for 2025 by clicking this link